• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imatron lands Malaysian CT order

Article

Imatron has won an order for five of its ultrafast CT scanners from a medical investment group in Malaysia in an agreement that is worth $13 million over the next two-and-a-half years to the South San Francisco, CA, company. The Malaysian group is called

Imatron has won an order for five of its ultrafast CT scanners from a medical investment group in Malaysia in an agreement that is worth $13 million over the next two-and-a-half years to the South San Francisco, CA, company. The Malaysian group is called Heart Scan Malaysia, but is unaffiliated with Imatron or its HeartScan Imaging subsidiary. Heart Scan Malaysia intends to develop a network of ultrafast CT centers in the country to provide cardiac diagnostic services.

In other Imatron news, the company last month reported 1996 year-end financial results (end-December) that included a net loss of $10.5 million on revenues of $25.8 million. That compares with a net loss of $2.4 million on revenues of $26.7 million in 1995.

Imatron said its year-end loss included $4.6 million in losses associated with HeartScan Imaging, of which Imatron owns 49.5%. Imatron also reported that shipments for the first quarter of 1997 are up 33% over the same period last year.

Finally, Imatron reported this month that Rush-Presbyterian-St. Luke's Medical Center of Chicago has opened Rush Heart Scan, a new coronary heart disease diagnosis and treatment facility that is using an ultrafast CT scanner. Rush Heart Scan is not affiliated with Imatron's HeartScan Imaging subsidiary.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.